NRC Stock Analysis: Buy, Sell, or Hold?
NRC - National Research Corporation Common Stock (Delaware)
$21.53
0.28 (1.32%)
â˛
5d:
-1.46%
30d:
+10.58%
90d:
+12.49%
WAIT
LOW Confidence
Analysis Updated: Sep 4, 2026 12:00 AM ET
Earnings: Oct 26, 2026
Get Alerted When NRC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: NRC is fairly priced but lacks strong directional signals. At 0.6% expected growth, valuation appears fair. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: NRC is fairly priced but lacks strong directional signals. At 0.6% expected growth, valuation appears fair. Wait for clearer setup or better entry on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$41.10
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$25.52
15.6% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 20.1x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: NRC is currently trading at $21.53, which is considered slightly high relative to its 30-day fair value range of $19.83 to $22.03. The stock's valuation (Forward PE: 20.5) is in line with its historical norms (20.1). At these levels, the market is pricing in 0.6% annual earnings growth.
Technical Outlook: Technically, NRC is in a strong uptrend. Immediate support is located at $19.93, while resistance sits at $22.52.
Market Sentiment: The stock scores a mixed 56/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $26.00 (+20.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, NRC is in a strong uptrend. Immediate support is located at $19.93, while resistance sits at $22.52.
Market Sentiment: The stock scores a mixed 56/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $26.00 (+20.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$19.83 -
$22.03
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
68.6%
All Signals
- NEUTRAL: Mixed technical signals (56/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 20.8% below Wall St target ($26.00)
- BULLISH: Expecting earnings turnaround to 0.6% growth with 4.0% revenue growth
- WARNING: Composite score 51/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$19.83 -
$22.03
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$19.93
Resistance Level
$22.52
Current Trend
Strong Uptrend
Technical data as of
Sep 4, 2026
Fundamental Context
Forward P/E (Next Year Est.)
20.50
Wall Street Target
$26.00
(+20.8%)
Revenue Growth (YoY)
4.0%
Earnings Growth (YoY)
-44.0%
Profit Margin
4.2%
Valuation Premium vs History
+0.6% premium
PE vs Historical
20.5 vs 20.1
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+0.6%
(market-implied from PE analysis)
1-Year Target
$21.66
(+1%)
2-Year Target
$21.79
(+1%)
3-Year Target
$21.92
(+2%)
3-Yr Target (if PE normalizes)
(PE: 21â20)
PE COMPRESSION
$21.49
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.5, Growth: 218.2%)
$72.66
(+238%)
Base:
(SPY PE: 20.2, Growth: 218.2%)
$71.69
(+233%)
Bear:
(PE: 17.2, Growth: 218.2%)
$60.94
(+183%)
đ
Valuation based on Current Earnings
Forward PE: 17.21 | Forward EPS (Implied): $1.25
Bull Case
$26.00
(+21%)
Analyst growth 15.0%, PE expands to 18.1
Base Case
$21.53
(0%)
Market implied 0.0%, PE stable at 17.2
Bear Case
$16.47
(-24%)
Severe decline -15.0%, PE contracts to 15.5
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: September 04, 2026 9:03 PM ET
Data refreshes hourly during market hours. Next update: 10:03 PM
Data refreshes hourly during market hours. Next update: 10:03 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NRC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$32 | 57 HOLD |
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$294 | 34 SELL |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$14 | 56 HOLD |
|
GEHC
GE HealthCare TechnologiâĻ |
STRONG BUY
21 analysts |
$90 | 48 HOLD |
|
BTSG
BrightSpring Health ServâĻ |
STRONG BUY
12 analysts |
$79 | 58 HOLD |
